Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0301586 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Rebecca Kampi und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda. Hauptthemen laut MEDLINE: Disclosure, Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FIC NIH HHS, Fogarty International Center.
Abstract (Originalsprache)
Introduction
While there have been several studies examining the understanding and quality of informed consent in clinical trials of cancer therapies, there is limited empirical research on health practitioners’ experiences on the informed consent process in cancer care, especially from low resource settings. This study explored health professionals’ perspectives on information disclosure during the consenting process in cancer care.
Methods
A qualitative descriptive approach was used to collect data. Face to face interviews were conducted with 10 purposively selected healthcare professionals who were actively involved in soliciting informed consent at a cancer treatment centre in Uganda. A thematic approach was used to interpret the results.
Results
There were five key themes, and these included information disclosure to patients; assessment of patients’ cancer awareness, treatment preferences and expectations; informed consent practices; barriers to optimal informed consent and information disclosure; and recommendations for improving the consenting process. All respondents appreciated the value of disclosing accurate information to patients to facilitate informed decision making. However, the informed consent process was deemed sub-optimal. Respondents asserted that patients should be the psychological wellbeing of patients should be protected by mentally preparing them before disclosing potentially distressing information. All healthcare professionals were appreciative of the central role the family plays in the consenting process.
Conclusion
Overall, informed consent practices were not ideal because of the several challenges. Inadequate time is devoted to information disclosure and patient education; there is lack of privacy; and informed consent documentation is poor. There is a need for significant improvement in informed consent practices and healthcare professional-patient communication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda.
- Uganda Cancer Institute, Kampala, Uganda.
ORCID-Profile: Erisa Sabakaki Mwaka
Förderung
- FIC NIH HHS
- Fogarty International Center
Zitieren
APA
Kampi, R., Okello, C., Ochieng, J., & Mwaka, E. S. (2024). Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda. PLOS ONE. https://doi.org/10.1371/journal.pone.0301586
Vancouver
Kampi R, Okello C, Ochieng J, Mwaka ES. Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda. PLOS ONE. 2024. doi:10.1371/journal.pone.0301586
BibTeX
@article{Kampi2024,
author = {Kampi, Rebecca and Okello, Clement and Ochieng, Joseph and Mwaka, Erisa Sabakaki},
title = {Informed consent in cancer clinical care: Perspectives of healthcare professionals on information disclosure at a tertiary institution in Uganda},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0301586}
}
EUVIMED